Author

Shalini Bagga

Observed names: Bagga, Shalini, S Bagga

OpenAlex ID: A5035146004

Time and productivity loss associated with immunotherapy infusions for the treatment of melanoma in the United States: a survey of health care professionals and patients

2023 · Raquel Aguiar-Ibáñez, Emilie Scherrer, et al. · BMC Health Services Research · 5

897 Infusion episode-related benefits of pembrolizumab Q6W dosing schedule for patients with melanoma treated in the adjuvant and metastatic settings in the United States (US)

2021 · Raquel Aguiar-Ibanez, Emilie Scherrer, et al. · Journal for ImmunoTherapy of Cancer · 3

CO90 Efficacy and Safety of Antibody-Drug Conjugates (ADCs) in Pretreated Locally Advanced/Metastatic (LA/m) Non-Small Cell Lung Cancer (NSCLC): A Systematic Literature Review (SLR)

2025 · Patricia Dorling, Shalini Bagga, et al. · Value in Health

CO216 Safety and Efficacy of Antibody Drug Conjugate (ADCs) in Pretreated Locally Advanced/Metastatic (LA/m) Triple-Negative Breast Cancer (TNBC): Systematic Literature Review (SLR)

2025 · Patricia Dorling, Shalini Bagga, et al. · Value in Health

SA53 Understanding the Real-World Evidence Published on FDA-Approved Immunotherapies in Oncology in the United States — a Targeted Literature Review

2022 · V Khurana, P Soni, et al. · Value in Health

Works count: 8

Citation count: 8

H-index: 2

I10-index: